Skip to content

Endoscopic Grading of Intestinal Metaplasia

Endoscopic Grading of Gastric Intestinal Metaplasia: a Validation Study in Korea

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05345314
Enrollment
242
Registered
2022-04-25
Start date
2022-03-01
Completion date
2023-04-24
Last updated
2023-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Intestinal Metaplasia, Magnifying Endoscopy, Narrow-band Imaging

Brief summary

Long-term Helicobacter pylori infection causes premalignant gastric conditions, such as atrophic gastritis and intestinal metaplasia. Image-enhanced endoscopy techniques such as narrow-band imaging (NBI) and magnifying endoscopy improve the diagnosis of gastric intestinal metaplasia (GIM). However, there are no comparative data on the utility of NBI and magnifying endoscopy for diagnosing GIM.

Detailed description

This study aims to evaluate the diagnostic performance of NBI and magnifying endoscopy for GIM in a country with high risk of gastric premalignant lesions.

Interventions

PROCEDURENarrow-band imaging endoscopy

During endoscopy, gastric mucosal patterns would be examined by magnifying narrow-band imaging.

Sponsors

Soonchunhyang University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years

Inclusion criteria

* Gastroscopy can be performed * Pathological analysis can be performed for analysis of gastric atrophy and intestinal metaplasia

Exclusion criteria

* Age \< 20 or \> 80 years * Anemia (serum hemoglobin level \< 10 g/dL) * Severe systemic disease * Advanced chronic liver disease * Use of certain medications, including proton pump inhibitors, H2-receptor antagonists, or antibiotics * History of H. pylori eradication * History of gastric surgery * Recent history of upper gastrointestinal bleeding

Design outcomes

Primary

MeasureTime frameDescription
Gastric intestinal metaplasia4 weeksGastric intestinal metaplasia would be assessed using pathological examination.

Secondary

MeasureTime frameDescription
Degree of chronic gastritis4 weeksGastric atrophy would be evaluated on the basis of histopathological examination (updated Sydney system).

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026